Are New Therapies on the Horizon for Painful Skin Condition?
UCSF's HS PROGRESS study aims to understand and treat Hidradenitis Suppurativa, an often debilitating condition disproportionately affecting women and people of color.
University of California San Francisco
Give to UCSFUCSF's HS PROGRESS study aims to understand and treat Hidradenitis Suppurativa, an often debilitating condition disproportionately affecting women and people of color.
Diana Greene Foster, leader of a groundbreaking study on what happens to women who are denied abortions, has been named a 2023 MacArthur Fellow, one of the most coveted honors in academia, science and the arts.
Zuranolone (Zurzuvae), the first pill for patients suffering from postpartum depression, is expected to be available by the end of 2023. Though it may relieve depressive symptoms, it has some drawbacks such as sedation and dangers in breastfeeding.
Vizient Inc. has named UCSF Health as a Top Performer for its high-quality patient care in the 2023 Bernard A. Birnbaum, MD, Quality Leadership Ranking.
Convergent evolutionary mechanisms shared by COVID-19 variants allow them to overcome both adaptive and innate immune system barriers.
Recommendations are in place for the updated COVID-19 vaccine from Pfizer-BioNTech and Moderna.
Researchers have found that people who developed breast, ovary, skin and uterine cancers have significantly higher levels of endocrine-disrupting chemicals in their bodies.
The FDA recently approved the world’s first vaccines to prevent RSV for infants and elderly adults.
A new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this preventable, treatable and curable disease.
Three injectable medications, Wegovy, Ozempic and Mounjaro, are often taken as weight management drugs. UCSF health experts weigh in on the benefits and risks of taking the medications for obesity.